Medicine Grade Indomethacin Capsules

Model NO.: IC01 Customized: Customized Suitable for: Elderly, Children, Adult Product: Indomethacin Capsules Specification: 25mg/50mg*10caps*10blisters/Box, GMP and GSP Shelf Life: Three Years Package: We Can Do as UR Requirement or Can Use Our Own PAC Origin: China Powder: No Certification: GMP State: Solid Ingredient: Indomethacin Is Available in 25 Mg and 50 Mg Capsu Pharmaceutical Form: Capsule Storage: Store at 20° to 25° C Remark: OEM Available
Specifications
1. indomethacin capsules,GMP Certificate approved 
2.Good quality and Reasonable price .finished medicine.
 
Indomethacin Capsules
 

Product:	Indomethacin capsules
Ingredient:	Indomethacin is available in 25 mg and 50 mg capsules For Oral administration
Specification:	25mg/50mg*10caps*10blisters/box
Pharmaceutical form	Capsule
Therapeutic indications:	Carefully consider the potential benefits and risks of indomethacin and other treatment options before deciding to use indomethacin. Use the lowest effective dose for the shortest duration consistent with individual patient treatment goals (see WARNINGS).   Indomethacin capsules have been found effective in active stages of the following: Moderate to severe rheumatoid arthritis including acute flares of chronic disease. Moderate to severe ankylosing spondylitis. Moderate to severe osteoarthritis. Acute painful shoulder (bursitis and/or tendinitis). Acute gouty arthritis.
Posology and method of administration	Pediatric Use Indomethacin ordinarily should not be prescribed for pediatric patients 14 years of age and under (see PRECAUTIONS, Pediatric Use). Adult Use Dosage Recommendations for Active Stages of the Following: 1. Moderate to severe rheumatoid arthritis including acute flares of chronic disease; moderate to severe ankylosing spondylitis; and moderate to severe osteoarthritis. Suggested Dosage: Indomethacin capsules 25 mg b.i.d. or t.i.d. If this is well tolerated, increase the daily dosage by 25 or by 50 mg, if required by continuing symptoms, at weekly intervals until a satisfactory response is obtained or until a total daily dose of 150 to 200 mg is reached. DOSES ABOVE THIS AMOUNT GENERALLY DO NOT INCREASE THE EFFECTIVENESS OF THE DRUG. In patients who have persistent night pain and/or morning stiffness, the giving of a large portion, up to a maximum of 100 mg, of the total daily dose at bedtime, may be helpful in affording relief. The total daily dose should not exceed 200 mg. In acute flares of chronic rheumatoid arthritis, it may be necessary to increase the dosage by 25 mg or, if required, by 50 mg daily. If minor adverse effects develop as the dosage is increased, reduce the dosage rapidly to a tolerated dose and OBSERVE THE PATIENT CLOSELY. If severe adverse reactions occur, STOP THE DRUG. After the acute phase of the disease is under control, an attempt to reduce the daily dose should be made repeatedly until the patient is receiving the smallest effective dose or the drug is discontinued. Careful instructions to, and observations of, the individual patient are essential to the prevention of serious, irreversible, including fatal, adverse reactions. As advancing years appear to increase the possibility of adverse reactions, indomethacin should be used with greater care in the elderly (see PRECAUTIONS, Geriatric Use). 2. Acute painful shoulder (bursitis and/or tendinitis). Initial Dose: 75 to 150 mg daily in 3 or 4 divided doses. The drug should be discontinued after the signs and symptoms of inflammation have been controlled for several days. The usual course of therapy is 7 to 14 days. 3. Acute gouty arthritis. Suggested Dosage: Indomethacin Capsules 50 mg t.i.d. until pain is tolerable. The dose should then be rapidly reduced to complete cessation of the drug. Definite relief of pain has been reported within 2 to 4 hours. Tenderness and heat usually subside in 24 to 36 hours, and swelling gradually disappears in 3 to 5 days.
Contraindications:	Indomethacin is contraindicated in patients with known hypersensitivity to indomethacin or the excipients (see DESCRIPTION). Indomethacin should not be given to patients who have experienced asthma, urticaria, or allergic-type reactions after taking aspirin or other NSAIDs. Severe, rarely fatal, anaphylactic/anaphylactoid reactions to NSAIDs have been reported in such patients (see WARNINGS, Anaphylactic/Anaphylactoid Reactions, and PRECAUTIONS, Preexisting Asthma). Indomethacin is contraindicated for the treatment of peri-operative pain in the setting of coronary artery bypass graft (CABG) surgery (see WARNINGS).
Shelf Life:	Three years.
Storage:	Store at 20° to 25° C
Package	We can do as ur requirement or can use our own package
Remark:	OEM available

Contact us if you need more details on Medicine. We are ready to answer your questions on packaging, logistics, certification or any other aspects about Chemicals、Pharmaceutical. If these products fail to match your need, please contact us and we would like to provide relevant information.

Product Categories : Capsules